Chronic myeloid leukemia, or CML, is a blood cancer that's defined by a specific genetic change. Doctors have been using drugs that target this change, called tyrosine kinase inhibitors, to treat CML. These drugs have been a game-changer, but some patients don't respond well and their condition worsens. Now, scientists are looking deeper into the DNA of CML cells. Th...

Rare conditions might affect a small group of people, but they collectively impact around 300 million globally. In the past, early diagnosis was challenging due to the failure to recognize rare conditions and order the right genomic tests. However, advancements in genome sequencing now offer a faster and more comprehensive way to identify and diagnose rare disorders....